Literature DB >> 18790953

The role of novel drugs in multiple myeloma.

M A Dimopoulos1, E Kastritis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18790953     DOI： 10.1093/annonc/mdn444

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

Review 1.  Lenalidomide: a review of its use in the treatment of relapsed or refractory multiple myeloma.

Authors:  Lesley J Scott; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2011-03-26       Impact factor: 9.546

Review 2.  Lenalidomide: a review of its continuous use in patients with newly diagnosed multiple myeloma not eligible for stem-cell transplantation.

Authors:  Paul L McCormack
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

3.  Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity.

Authors:  Marie-Christine Kyrtsonis; Vassiliki Bartzis; Xenophon Papanikolaou; Efstathios Koulieris; George Georgiou; Maria Dimou; Tatiana Tzenou; Panayiotis Panayiotidis
Journal:  Appl Clin Genet       Date:  2010-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.